Specify a stock or a cryptocurrency in the search bar to get a summary
Shanghai Hile Bio-tech
603718Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis. It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease, and avian infectious bronchitis combined live vaccines. The company was founded in 1981 and is based in Shanghai, China. Address: Room 1805, Shanghai, China, 200021
Analytics
WallStreet Target Price
108.49 CNYP/E ratio
845Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 603718
Dividend Analytics 603718
Dividend growth over 5 years
3 %Continuous growth
1 yearPayout Ratio 5 years average
40 %Dividend History 603718
Stock Valuation 603718
Financials 603718
Results | 2019 | Dynamics |